Impact Biomedical Inc. (IBO) — 10-Q Filings

10-Q Filings (6)

• IBO's Cash Dries Up Amidst $17.1M Loss, Related Party Debt Soars — Nov 7, 2025 Risk: high
  IMPACT BIOMEDICAL INC. (IBO) reported a significant net loss of $17,105,000 for the nine months ended September 30, 2025, a stark contrast to the net income of
• IBO's Net Loss Skyrockets to $15.6M Amidst Soaring Related-Party Debt — Aug 14, 2025 Risk: high
  IMPACT BIOMEDICAL INC. (IBO) reported a significant increase in net loss for the six months ended June 30, 2025, reaching $(15,631,000) compared to $(1,880,000)
• Impact Biomedical Inc. Files Q1 2025 10-Q — May 14, 2025 Risk: low
  Impact Biomedical Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2025. The company, incorporated in Nevada, operates in the pharma
• Impact Biomedical Inc. Files Q3 2024 10-Q — Nov 12, 2024 Risk: low
  Impact Biomedical Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the fiscal year
• Impact Biomedical Inc. Files Q2 2024 10-Q — Aug 13, 2024 Risk: medium
  Impact Biomedical Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quart
• IMPACT BIOMEDICAL INC. Files 10-Q for Period Ending March 31, 2024 — May 10, 2024 Risk: low
  IMPACT BIOMEDICAL INC. (IBO) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. IMPACT BIOMEDICAL INC. filed a 10-Q for the quarterly period ended Ma

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX